St. Jude Medical Inc.STJ recently announced the receipt of CE Mark approval for its Infinity Deep Brain Stimulation ("DBS") System and directional DBS lead, allowing sale in the European market. The ...

Infinity Deep Brain Stimulation System--Courtesy of St. Jude Medical St. Jude Medical ($STJ) has received a CE mark for its latest neuromodulation technology--the ...

Abbott Laboratories had a winning week, scoring U.S. FDA approval of its Infinity directional deep brain stimulation (DBS) system in treating symptoms of Parkinson’s disease not adequately managed by ...

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval for the St. Jude Medical Infinity™ Deep Brain Stimulation (DBS) System and directional DBS lead.

Abbott Laboratories had a winning week, scoring U.S. FDA approval of its Infinity directional deep brain stimulation (DBS) system in treating symptoms of Parkinson’s disease not adequately managed by ...

St. Jude Medical, Inc., a global medical device company, announced the United States Food and Drug Administration approval and first implant of the St. Jude Medical Infinity Deep Brain Stimulation ...

Abbott announced it received approval from the US Food and Drug Administration (FDA) for a new, expanded indication for the company's Infinity Deep Brain Stimulation (DBS) system to include targeting ...

The US Food and Drug Administration (FDA) has approved a new software upgrade for Abbott's Infinity deep-brain stimulation (DBS) system used in patients with Parkinson's disease and essential tremor, ...

Medical device major St. Jude Medical, Inc. STJ recently announced the U.S. FDA approval and first implant of its St. Jude Medical Infinity Deep Brain Stimulation (DBS) system. Its DBS directional ...

Medical device major St. Jude Medical, Inc.STJ recently announced the U.S. FDA approval and first implant of its St. Jude Medical Infinity Deep Brain Stimulation (DBS) system. Its DBS directional ...